Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott posts latest financial results

Abbott posts latest financial results

15th October 2009

Abbott has unveiled its financial results for the third quarter of the year, posting earnings growth of 16.5 per cent.

It reported an increase of 8.4 per cent in its worldwide operational sales, a 16.2 per cent rise in its medical products operational sales and growth of 15.2 per cent in international pharmaceutical sales.

The company has also raised its earnings-per-share outlook for 2009.

Furthermore, Abbott completed several acquisitions during the timeframe, namely those of pharmaceutical firm Solvay, cardiac mitral valves manufacturer Evalve and intraocular lens supplier Visiogen.

Miles White, chairman and chief executive officer of the company, commented: “These acquisitions add to our diverse mix of global businesses, with new technologies, established products and emerging market infrastructure that will help us deliver sustainable industry-leading growth.”

The firm’s financial details come after its AKI diagnosis kit – designed for those with suspected acute kidney injury – received the CE mark last week.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.